
William Carroll MD
Professor of Pediatrics, NYU School of Medicine
Join to view full profile
317 E 34th StNew York, NY 10016
Phone+1 212-263-8400
Dr. Carroll is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 1982 - 1983
Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 1979 - 1982
University of Cincinnati Medical Center Inc.Internship, Transitional Year, 1978 - 1979
University of California, Irvine, School of MedicineClass of 1978
California State University, ChicoB.A., Biological Sciences, Magna Cum Laude, 1969 - 1973
Certifications & Licensure
CA State Medical License 1982 - Present
NY State Medical License 2001 - 2028
FL State Medical License 2020 - 2022
UT State Medical License 1991 - 2002
OH State Medical License 1979 - 1982
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
Publications & Presentations
PubMed
- Reaching consensus in relapsed/refractory ALL in AYAs.Elizabeth A Raetz, William L Carroll
Blood Advances. 2026-07-14 - 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia.Yohana E Ghebrechristos, Nikki A Evensen, Romane S Cathelin, Soobeom Lee, Finnegan Clark
Blood Cancer Discovery. 2026-07-01 - Detection of MEN1 resistance mutations in cell-free DNA from acute leukemia patients treated with menin inhibitors.Neerav Shukla, Karmelina Charalambous, Shanita Li, Kaitlyn H Ko, Hilary Casanova
Blood Cancer Journal. 2026-06-16
Journal Articles
- Loss of TBLXR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in childhood B-Lymphoblastic leukemia modelJones CL, Bhatla T, Wang J, Bourgeois W, Bitterman D, Raetz E, Morrison D, Teachey D, Garabedian M, Carroll WL, J Biol Chem, 6/1/2014
- A Prospective Study of Anxiety, Depression, and Behavioral Changes in the First Year after Diagnosis of Childhood Acute Lymphoblastic LeukemiaMyers RM, Balsamo L, Lu X, Devidas, M, Hunger SP, Carroll WL, Winick NJ, Maloney KW, and Kadan-Lottick NS, Cancer, 5/1/2014
- Philadelphia chromosome negative very high risk acute lymphoblastic leukemia (ALL) in children and adolescents: results from children's oncology group (COG) study AALL...Schultz KR, Devidas M, Bowman WP, Aledo A, Slayton WB, Sather H, Zheng HW, Davies SM, Gaynon PS, Trigg M, Rutledge R, Jorstad D, Carroll AJ, Heerema N, Winick N, Borow..., Leukemia, 4/1/2014
Books/Book Chapters
Abstracts/Posters
- The Genomic Landscape of Childhood Acute Lymphoblastic LeukemiaWilliam L. Carroll, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Germline RUNX1 Variation and Predisposition to T-Cell Acute Lymphoblastic Leukemia in ChildrenWilliam L. Carroll, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- FLT3 Inhibitor Correlative Laboratory Assays Impact Outcomes in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia (ALL) Patients Treated with Lestaurtinib: AALL0631...William L. Carroll, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Treating Childhood Leukemia in the Age of Genomics.Mount Sinai Medical Center, New York, NY - 2/13/2014
- The Evolutionary Forces That Drive Treatment Failure In Childhood Cancer – Lessons Learned from Treating Acute Lymphoblastic Leukemia.Hershey, PA - 10/25/2013
- The Genetic and Molecular Evolution of Relapsed ALL-Clues to Drug Resistance Pathways.Washington, DC - 9/16/2013
Press Mentions
p73α Isoforms Drive Opposite Transcriptional and Post-Transcriptional Regulation of MYCN Expression in Neuroblastoma CellsJune 25th, 2020
NYU Cancer Institute Experts Present at American Society of Clinical Oncology Annual Meeting: June 4- 8, 2010March 30th, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









